Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

NCT04920097 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT04920097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Not applicable
Overall status
Completed
Start date
July 8, 2021
Completion date
March 19, 2026
Enrollment
238 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced neuropathy